Sabnani, I <br/><br/>
A novel therapeutic approach to the treatment of scleroderma-associated pulmonary complications: safety and efficacy of combination therapy with imatinib and cyclophosphamide.  [electronic resource] 

 -  Rheumatology (Oxford, England)  Jan 2009 
 - 49-52 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article 
<br/><br/><label>ISSN: </label>1462-0332 
<br/><br/><label>Standard No.: </label>10.1093/rheumatology/ken369  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Benzamides<br/>Cyclophosphamide--adverse effects<br/>Drug Therapy, Combination<br/>Female<br/>Follow-Up Studies<br/>Humans<br/>Imatinib Mesylate<br/>Immunosuppressive Agents--adverse effects<br/>Lung Diseases, Interstitial--drug therapy<br/>Male<br/>Middle Aged<br/>Piperazines--adverse effects<br/>Protein Kinase Inhibitors--adverse effects<br/>Protein-Tyrosine Kinases--antagonists & inhibitors<br/>Pyrimidines--adverse effects<br/>Scleroderma, Systemic--complications<br/>Treatment Outcome